Previse

Most procurement data isn't broken-it's fragmented. Discover how entity resolution unites your supplier data, removes hidden costs, and makes AI actually work.

When one supplier appears 20+ times across your systems, it's not just messy data - it's lost negotiating power, invisible overpayments, and procurement chaos. Before you can deploy AI in procurement, you need to fix this foundation.

We've received a Notice of Allowance for a patent that extends automation beyond payments to comprehensive procure-to-pay intelligence.

For years, your AP team has been processing invoices and keeping suppliers happy: important work, but hardly strategic. But in 2025, the rules have changed.

Every CFO has asked the question: Where exactly is our money going? And across industries, from logistics and healthcare to manufacturing and insurance, the answer is often unclear.

Explore how Previse evaluates leading GenAI platforms to build AI-native infrastructure for finance. Learn why model flexibility matters, how platform choice impacts performance, and what it takes to future-proof intelligent procure-to-pay and payment wor

True P2P transformation takes more than AI agents. Discover why data quality, orchestration, and platform design are critical to scaling intelligent procurement and finance operations - and how to move beyond siloed automation towards cohesive, enterprise

Finance, procurement, and treasury teams are sitting on mountains of data-but large language models (LLMs) now make it possible to unlock insights at scale. We explain how batch LLM inference can drive efficiency, improve compliance, and optimise supplier

Castle Biosciences signed a definitive agreement to acquire Capsulomics, Inc., which does business as Previse.

media615119